Stang E, Roos N, Schlüter M, Berg T, Krause J
Electronmicroscopical Unit for Biological Sciences, University of Oslo, Blindern, Norway.
Biochem J. 1992 Aug 1;285 ( Pt 3)(Pt 3):799-804. doi: 10.1042/bj2850799.
In the liver, tissue-type plasminogen activator (t-PA) is endocytosed by hepatic parenchymal (PC), endothelial (EC) and Kupffer (KC) cells. Although the endocytosis is receptor-mediated, it remains a matter of discussion which receptors are involved in this catabolic process. To evaluate the role of a protein-specific receptor, as well as the possible involvement of the galactose receptor on PC and the mannose receptor on EC, we have employed different glycosylation variants of t-PA in biochemical and immunocytochemical studies. Partial or total removal of carbohydrate side-chains by endoglycosidases did not prevent clearance and hepatic endocytosis of t-PA by either of the liver cell types. Blockade of the galactose and mannose receptors by co-application of a large excess of the glycoprotein ovalbumin remained without effect on the binding and uptake of t-PA by hepatic cells. However, the contribution of different liver cell types to the hepatic clearance of t-PA was to a certain extent dependent on the type of oligosaccharide chains removed. The mannose receptor on EC is partially responsible for the clearance of t-PA by this cell type, whereas the galactose receptor does not seem to be involved in this process. The results obtained in this study further demonstrate that the major portion of the hepatic catabolism of t-PA is independent of its carbohydrate side-chains.
在肝脏中,组织型纤溶酶原激活物(t-PA)被肝实质细胞(PC)、内皮细胞(EC)和库普弗细胞(KC)内吞。尽管这种内吞作用是由受体介导的,但参与这一分解代谢过程的是哪些受体仍存在争议。为了评估蛋白质特异性受体的作用,以及PC上半乳糖受体和EC上甘露糖受体可能的参与情况,我们在生化和免疫细胞化学研究中使用了不同糖基化变体的t-PA。用内切糖苷酶部分或完全去除碳水化合物侧链并不能阻止任何一种肝细胞类型对t-PA的清除和肝内吞作用。通过共同应用大量糖蛋白卵清蛋白来阻断半乳糖和甘露糖受体,对肝细胞结合和摄取t-PA没有影响。然而,不同肝细胞类型对t-PA肝脏清除的贡献在一定程度上取决于去除的寡糖链类型。EC上的甘露糖受体部分负责该细胞类型对t-PA的清除,而半乳糖受体似乎不参与这一过程。本研究获得的结果进一步证明,t-PA肝脏分解代谢的主要部分与其碳水化合物侧链无关。